Siemens grows its digital twin strategy into life sciences market

Siemens has agreed to acquire Dotmatics, the developer of a data platform for scientific research, taking it into the life sciences market.

Siemens plans to combine Dotmatics’ drug research and development applications with its manufacturing industry expertise to create an AI-powered research-to-manufacturing digital thread for the life sciences vertical, the company said in a slide deck aimed at investors.

Rohit K, practice director at Everest Group, said the companies’ combined offering will provide their joint customers with predictive modeling, faster iteration cycles, and stronger regulatory compliance—ultimately accelerating time-to-market.